Centre for Pharmaceutical Sciences, Institute of Science and Technology, Jawaharlal Nehru Technological University, Hyderabad.
*Corresponding Author E-mail: surekhantpc@gmail.com
Online published on 19 April, 2013.
Buccal route is one of the promising area where continuous research is going on in order to increase the bioavailability of most of the drugs effected by first pass metabolism and also to increase possibility of oral delivery of protein and peptide drugs with high patient compliance. In order to achieve the required target of bioavailability, drugs are formulated in different buccal dosage forms. The objective of this article is to enlighten the commercial products of various buccal dosage forms and their evaluation.
Buccal route, first pass metabolism, bioavailability, oral mucosa, marketed products
